Telix Pharmaceuticals Limited (TLX)
US$ 18.8-2.19%
Price Chart
Key Statistics
Market Cap
$ 5.23B
P/E Ratio
173.44
Revenue (TTM)
$ 645.68M
Volume
28.85K
52W High
$ 30.36
52W Low
$ 13.61
Dividend Yield
0.00%
Beta
2.38
Technicals
50-Day MA
15.6043
200-Day MA
15.6043
52 Week High
30.36
52 Week Low
13.61
About TLX
Telix Pharmaceuticals Limited, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals for cancer and rare dis.
Employees
N/A
Headquarters
North Melbourne, VIC
CEO
Dr. Christian P. Behrenbruch BEng(Hons), DPhil(Oxon), GAICD, J.D., M.B.A., MBA
Latest News
Talex (WSE:TLX) Has Announced That Its Dividend Will Be Reduced To PLN0.25 - simplywall.st
17 hours ago • Google News
Here's Everything I Liked And Didn't Like About The 2024 Acura TLX Type S - Top Speed
2024-10-30 • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg